Branch² Intelligence
From hypertension to diabetes, National Pharmaceutical Pricing Authority caps retail price of 39 medicines
Key takeaway
NPPA caps retail prices of 39 drugs for hypertension, diabetes, and heart disease under DPCO.
- Step 1NPPA caps retail prices of 39 drugs under DPCO, forcing manufacturers to lower prices.
- Step 2Generic drug manufacturers' margins compress, especially for high-volume chronic therapies.
- Step 3Pharmacies and hospital dispensaries face reduced per-unit revenue, potentially offset by volume increases.
- Step 4Patients benefit from lower out-of-pocket costs, improving adherence and potentially increasing overall drug consumption.
Source: CNBC TV18 (Markets)
This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.